West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

Press releases published on July 13, 2026

Jul. 13, 2026

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development

Indeterminate GlobeNewswire

Jul. 13, 2026

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

Indeterminate GlobeNewswire

Jul. 13, 2026

Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial

Indeterminate GlobeNewswire

Jul. 13, 2026

Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio

Indeterminate GlobeNewswire

Jul. 13, 2026

REPEAT - Grifols deaths and harm: Patient safety & options for accountability

Indeterminate GlobeNewswire

Jul. 13, 2026

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

Indeterminate GlobeNewswire

Jul. 13, 2026

FDA Grants De Novo Classification to Claria Medical for Device Designed to Improve Safety and Efficiency of Hysterectomy Procedures

Indeterminate GlobeNewswire

Jul. 13, 2026

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to…

Indeterminate GlobeNewswire

Jul. 13, 2026

Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

Indeterminate GlobeNewswire

Jul. 13, 2026

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

Indeterminate GlobeNewswire

Jul. 13, 2026

Bexorg Expands Leadership Team with Appointments of Bruce Car, Ph.D., as Chief Scientific Officer and Michael Fenn, Ph.D., as Chief Business Officer

Indeterminate GlobeNewswire

Jul. 13, 2026

Immutep Provides Clinical Update in 1st line NSCLC: Positive Mature Overall Survival Data from INSIGHT-003 and Update from TACTI-004

Indeterminate GlobeNewswire

Jul. 13, 2026

Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit

Indeterminate GlobeNewswire

Jul. 13, 2026

Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant

Indeterminate GlobeNewswire

Jul. 13, 2026

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease

Indeterminate GlobeNewswire

Jul. 13, 2026

VitalHub Announces Acquisition of Buddy Healthcare

Indeterminate GlobeNewswire

Jul. 13, 2026

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Indeterminate GlobeNewswire

Jul. 13, 2026

Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists

Indeterminate GlobeNewswire

Jul. 13, 2026

ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis

Indeterminate GlobeNewswire

Jul. 13, 2026

New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases

Indeterminate GlobeNewswire